Faster, cheaper genome advances propel cancer care

Genome-sequencing is getting cheaper and faster, and can eliminate the guesswork in treating cancer by offering personalized clues on how to best attack tumors, US doctors said on Tuesday.

The human genome was first sequenced in 2003, followed by the first cancer tumor in 2008, intriguing doctors with a new and unparalleled potential for targeting care.

However, controversy lingers over the ethical questions that arise as people begin to learn more about their genetic maps, from concerns over medical privacy to decisions about childbearing and scanning offspring for genetic flaws.

Two studies in the Journal of the American Medical Association detail how one patient's genome led doctors to a different, life-saving leukemia treatment, while a second patient died but left her three children with potentially valuable information about their genetic future.

The study authors said these cases offer hope that as technology gets cheaper and researchers build up more data about cancer and its various mutations, the oncology field will be transformed in the next five to 10 years.

What used to cost tens of millions of dollars and took months, now costs about $40,000 and can offer detailed results in about six weeks, said senior author Richard Wilson, director of Washington University's Genome Institute.

"It has been very eye opening for me in the 10 years that I have been working on cancer genomics," Wilson told AFP.

"We think about leukemia or lung cancer or breast cancer as all sort of being the same disease across all patients, but that's really not the way it is," he said.

"It is a complex genetic disease... for the great majority of the cases you are going to want to know exactly what is going on in the genome to cause the disease in order to effectively treat it."

One study centered on a 39-year-old woman who appeared to have classic case of acute promyelocytic leukemia (APL), but lacked the usual genetic signs associated with it.

By sequencing the genome of the patient and her tumor and comparing them, doctors found she had an unusual genetic insertion of one chromosome into another, which mimicked the sort of cancer best tackled with chemotherapy instead of a risky bone marrow or stem cell transplant.

"Sequencing the genome of the patient's leukemia cells offered the opportunity to resolve this dilemma in 'real time' and allowed us to make the correct call in recommending further therapy," said the patient's oncologist, Peter Westervelt at Washington University.

The patient came in with survival odds of less than 15 percent, received chemotherapy "and remains in remission 15 months after her diagnosis," the study said.

The second case involved a mother of three who was diagnosed with breast cancer at age 37, then developed ovarian cancer by age 39. She died at 42, after extensive chemotherapy and a recurrence of the ovarian tumor.

However, she had little family history of cancer, leading doctors to suspect she may have had some sort of genetic mutation.

She tested negative for the common BRCA1 and BRAC2 mutations that are often at the root of breast or ovarian cancer, but a sequencing of her entire genome showed "a novel and unexpected mutation in TP53, a well-known tumor suppressor gene involved in DNA repair," the study said.

Doctors said she was likely born with the mutation, which leaves a 50 percent chance of being passed on to her children, potentially handing them a 90 percent risk of developing cancer in their lifetimes.

Wilson said he was unaware of what her family decided to do with the information, due to patient confidentiality agreements, but that doctors recommended her children be tested.

"You always have people who say, 'We should pass this information along, or we shouldn't,'" Wilson said, pointing to the central ethical dilemma of such technological advances.

"The bottom line is that a mutation such as this, which is a clear cancer susceptibility marker, is actionable," he said.

"Your physician, if armed with this information, is going to be much more aggressive in checking for breast cancer early, or ovarian cancer early."

Hundreds of patients in the United States and Britain have had their genomes sequenced, and a handful of companies are speeding ahead with the technology, said Boris Pasche of the University of Alabama in Birmingham.

"The competition is quite fierce, which has benefited the consumers and researchers like us," Pasche said.

ksh/rl

 

Life and Style
ebookNow available in paperback
ebooks
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Web Developer - PHP

    £25000 - £30000 per annum: Recruitment Genius: This is an exciting opportunity...

    Recruitment Genius: Technical Support Engineer

    £18000 - £27000 per annum: Recruitment Genius: This established name in IT Ser...

    Recruitment Genius: Senior Electrician

    £27846 per annum: Recruitment Genius: With 50 years in business in 2015, this ...

    Recruitment Genius: Telesales Executive - OTE £45,000

    £18000 - £45000 per annum: Recruitment Genius: This market leader in the devel...

    Day In a Page

    Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

    Making of a killer

    What motivated a shy student to kill 38 holidaymakers in Tunisia?
    UK Heatwave: Temperatures on the tube are going to exceed the legal limit for transporting cattle

    Just when you thought your commute couldn't get any worse...

    Heatwave will see temperatures on the Tube exceed legal limit for transporting cattle
    Exclusive - The Real Stories of Migrant Britain: Swapping Bucharest for London

    The Real Stories of Migrant Britain

    Meet the man who swapped Romania for the UK in a bid to provide for his family, only to discover that the home he left behind wasn't quite what it seemed
    Cheaper energy on the way, but it's not all sunshine and rainbows

    Cheaper energy on the way, but it's not all sunshine and rainbows

    Solar power will help bring down electricity prices over the next five years, according to a new report. But it’s cheap imports of ‘dirty power’ that will lower them the most
    Katy Perry prevented from buying California convent for $14.5m after nuns sell to local businesswoman instead

    No grace of God for Katy Perry as sisters act to stop her buying convent

    Archdiocese sues nuns who turned down star’s $14.5m because they don’t approve of her
    Ajmer: The ancient Indian metropolis chosen to be a 'smart city' where residents would just be happy to have power and running water

    Residents just want water and power in a city chosen to be a ‘smart’ metropolis

    The Indian Government has launched an ambitious plan to transform 100 of its crumbling cities
    Michael Fassbender in 'Macbeth': The Scottish play on film, from Welles to Cheggers

    Something wicked?

    Films of Macbeth don’t always end well - just ask Orson Welles... and Keith Chegwin
    10 best sun creams for body

    10 best sun creams for body

    Make sure you’re protected from head to toe in the heatwave
    Wimbledon 2015: Nick Bollettieri - Milos Raonic has ability to get to the top but he must learn to handle pressure in big games

    Nick Bollettieri's Wimbledon files

    Milos Raonic has ability to get to the top but he must learn to handle pressure in big games
    Women's World Cup 2015: How England's semi-final success could do wonders for both sexes

    There is more than a shiny trophy to be won by England’s World Cup women

    The success of the decidedly non-famous females wearing the Three Lions could do wonders for a ‘man’s game’ riddled with cynicism and greed
    How to stop an asteroid hitting Earth: Would people co-operate to face down a global peril?

    How to stop an asteroid hitting Earth

    Would people cooperate to face a global peril?
    Just one day to find €1.6bn: Greece edges nearer euro exit

    One day to find €1.6bn

    Greece is edging inexorably towards an exit from the euro
    New 'Iron Man' augmented reality technology could help surgeons and firefighters, say scientists

    'Iron Man' augmented reality technology could become reality

    Holographic projections would provide extra information on objects in a person's visual field in real time
    Sugary drinks 'are killing 184,000 adults around the world every year'

    Sugary drinks are killing 184,000 adults around the world every year

    The drinks that should be eliminated from people's diets
    Pride of Place: Historians map out untold LGBT histories of locations throughout UK

    Historians map out untold LGBT histories

    Public are being asked to help improve the map